Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Excelerate Energy, Inc.Excelerate Energy Releases 2025 Sustainability Report, Highlighting Progress in Energy Security and Responsible GrowthTHE WOODLANDS, Texas, August 27, 2026--Excelerate Energy, Inc. (the "Company" or "Excelerate") (NYSE: EE) today announced the publication of its 2025 Sustainability Report, highlighting the Company’s efforts to strengthen energy security, operate responsibly, and create long-term value for customers, employees, communities, and shareholders.
- Powering What’s Next: Data Center World Power 2026 Puts Energy at the Center of the AI EconomyDALLAS, August 27, 2026--As artificial intelligence drives unprecedented demand for data center capacity, access to reliable power has emerged as one of the industry's defining challenges. Data Center World Power, taking place September 21-23 at the Gaylord Texan Resort & Convention Center in Dallas, will bring together data center operators, utilities, energy providers, technology innovators and infrastructure leaders to explore the strategies and technologies needed to power the industry's nex
- The World's Leading Minds in Biotechnology Will Meet in Riyadh This SeptemberRIYADH, KSA, Aug 28, 2026 - The Riyadh Global Medical Biotechnology Summit has published the scientific program for its fourth edition, and the names on it belong to the people currently deciding what medicine will be able to do in the next twenty years. Sixty confirmed speakers and moderators from eleven countries are named across three days, from 14 to 16 September 2026, at the Sofitel Riyadh Hotel and Convention Centre. Among them are Prof. Jin-Soo Kim of KAIST, whose work on mitochondrial DNA editing reaches beyond CRISPR; Dr. Matthew H. Porteus of Stanford University, engineering genetic circuits into cell-based medicines; Dr. Alex Shalek of MIT; Prof. Vijay Kuchroo of Harvard Medical School; Prof. Keith T. Flaherty of the Massachusetts General Hospital Cancer Center and President of the American Association for Cancer Research; Prof. George F. Gao of the Chinese Academy of Sciences; President Mitsuo Ochi of Hiroshima University; and Dr. Zdenko Herceg of the International Agency for Research on Cancer. They are joined by the people who move science into the world. Dr. Steve Yang, Co-CEO of WuXi AppTec, and Mr. Alec Reynolds of Flagship Pioneering open the program on global partnership. Mr. Kasim Kutay, Chief Executive Officer of Novo Holdings, speaks on where capital should go next. Dr. Hyun-Young Park, Deputy Minister of the Korea National Institute of Health, delivers the closing keynote. Alongside them stand the Saudi institutions building a biotechnology sector in real time: KAIMRC, Lifera, HUMAIN, SPIMACO, KAUST, the Saudi Food and Drug Authority, and Astronaut Rayyanah Barnawi on what the human immune system does in space. The program runs across six tracks: artificial intelligence in biotechnology, multi-omics, biotech investment, immunology, bioengineering and synthetic biology, and biotech workforce development. Its defining feature is that discovery and delivery share the same stage. Genome editing and population genomics sit beside regulation, domestic manufacturing, and procurement, and in several sessions the scientists and the regulators are on the same panel. That is the premise of the Kingdom's National Biotechnology Strategy, which targets $34.6 billion in non-oil GDP from biotechnology by 2040: a discovery is worth only as much as the system available to carry it to a patient. "Biotechnology is where the health of every nation will be decided over the next twenty years. Saudi Arabia has chosen not to watch that happen from a distance. We are building the laboratories, the manufacturing, the regulatory ecosystems, and above all, the bio-workforce talent. And we are building it in partnership with the world, under one roof. That is what this Summit is for. Its themes highlight where medicine and biotechnology converge to shape the future of biosciences. Discoveries and breakthroughs are transforming how we care for patients. The diversity of emerging technologies and therapies is creating significant opportunities to explore, advance, invest, and translate scientific progress into better health outcomes. Please join us in Riyadh this September." H.E. Prof. Bandar bin Abdulmohsen Al-Knawy, Chief Executive Officer of Health Affairs, Ministry of National Guard, and President, King Saud bin Abdulaziz University for Health Sciences The Summit is organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by King Abdullah International Medical Research Center (KAIMRC) and King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), with the Ministry of Investment and Invest Saudi serving as strategic partners. The fourth edition is expected to welcome more than 15,000 visitors, over 200 biotechnology and healthcare brands, and delegations from more than 70 countries, under the theme Building the Foundations of Biotechnology Excellence. The full scientific program is attached and available at rgmbs.org, where registration is open for delegates, exhibitors, and industry partners. Follow the Summit at #RGMBS2026. For further information regarding summit programing visit: https://rgmbs.org/program#conference-agenda About the Riyadh Global Medical Biotechnology Summit The Riyadh Global Medical Biotechnology Summit is the Kingdom of Saudi Arabia's flagship platform for medical biotechnology, convening the global scientific, investment, and policy communities in Riyadh. Organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by KAIMRC and KSAU-HS, the Summit advances the goals of the National Biotechnology Strategy and supports the Kingdom's emergence as a global destination for health innovation. The fourth edition takes place from 14 to 16 September 2026 in Riyadh. For Media Inquiry Email: [email protected] Telephone: +966 559 810 777
- Greener Game, Bigger Impact: Veolia Brings Sustainability Leadership to Pickleball Tournaments in North Carolina and Arizona with Professional Pickleball Association (PPA)Companies: VeoliaCARY, N.C. & MESA, Ariz., August 27, 2026--For the past three years, to support the growth of pickleball in the United States, Veolia, a global leader in the water, waste and energy sectors, is demonstrating how large sporting events can reduce waste and conserve resources through its ongoing partnership with the Professional Pickleball Association (PPA). Veolia sponsors six tournaments on the professional tour per year, including two tournaments this September:
- The World's Leading Minds in Biotechnology Will Meet in Riyadh This SeptemberRIYADH, KSA, Aug 28, 2026 - The Riyadh Global Medical Biotechnology Summit has published the scientific program for its fourth edition, and the names on it belong to the people currently deciding what medicine will be able to do in the next twenty years. Sixty confirmed speakers and moderators from eleven countries are named across three days, from 14 to 16 September 2026, at the Sofitel Riyadh Hotel and Convention Centre. Among them are Prof. Jin-Soo Kim of KAIST, whose work on mitochondrial DNA editing reaches beyond CRISPR; Dr. Matthew H. Porteus of Stanford University, engineering genetic circuits into cell-based medicines; Dr. Alex Shalek of MIT; Prof. Vijay Kuchroo of Harvard Medical School; Prof. Keith T. Flaherty of the Massachusetts General Hospital Cancer Center and President of the American Association for Cancer Research; Prof. George F. Gao of the Chinese Academy of Sciences; President Mitsuo Ochi of Hiroshima University; and Dr. Zdenko Herceg of the International Agency for Research on Cancer. They are joined by the people who move science into the world. Dr. Steve Yang, Co-CEO of WuXi AppTec, and Mr. Alec Reynolds of Flagship Pioneering open the program on global partnership. Mr. Kasim Kutay, Chief Executive Officer of Novo Holdings, speaks on where capital should go next. Dr. Hyun-Young Park, Deputy Minister of the Korea National Institute of Health, delivers the closing keynote. Alongside them stand the Saudi institutions building a biotechnology sector in real time: KAIMRC, Lifera, HUMAIN, SPIMACO, KAUST, the Saudi Food and Drug Authority, and Astronaut Rayyanah Barnawi on what the human immune system does in space. The program runs across six tracks: artificial intelligence in biotechnology, multi-omics, biotech investment, immunology, bioengineering and synthetic biology, and biotech workforce development. Its defining feature is that discovery and delivery share the same stage. Genome editing and population genomics sit beside regulation, domestic manufacturing, and procurement, and in several sessions the scientists and the regulators are on the same panel. That is the premise of the Kingdom's National Biotechnology Strategy, which targets $34.6 billion in non-oil GDP from biotechnology by 2040: a discovery is worth only as much as the system available to carry it to a patient. "Biotechnology is where the health of every nation will be decided over the next twenty years. Saudi Arabia has chosen not to watch that happen from a distance. We are building the laboratories, the manufacturing, the regulatory ecosystems, and above all, the bio-workforce talent. And we are building it in partnership with the world, under one roof. That is what this Summit is for. Its themes highlight where medicine and biotechnology converge to shape the future of biosciences. Discoveries and breakthroughs are transforming how we care for patients. The diversity of emerging technologies and therapies is creating significant opportunities to explore, advance, invest, and translate scientific progress into better health outcomes. Please join us in Riyadh this September." H.E. Prof. Bandar bin Abdulmohsen Al-Knawy, Chief Executive Officer of Health Affairs, Ministry of National Guard, and President, King Saud bin Abdulaziz University for Health Sciences The Summit is organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by King Abdullah International Medical Research Center (KAIMRC) and King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), with the Ministry of Investment and Invest Saudi serving as strategic partners. The fourth edition is expected to welcome more than 15,000 visitors, over 200 biotechnology and healthcare brands, and delegations from more than 70 countries, under the theme Building the Foundations of Biotechnology Excellence. The full scientific program is attached and available at rgmbs.org, where registration is open for delegates, exhibitors, and industry partners. Follow the Summit at #RGMBS2026. For further information regarding summit programing visit: https://rgmbs.org/program#conference-agenda About the Riyadh Global Medical Biotechnology Summit The Riyadh Global Medical Biotechnology Summit is the Kingdom of Saudi Arabia's flagship platform for medical biotechnology, convening the global scientific, investment, and policy communities in Riyadh. Organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by KAIMRC and KSAU-HS, the Summit advances the goals of the National Biotechnology Strategy and supports the Kingdom's emergence as a global destination for health innovation. The fourth edition takes place from 14 to 16 September 2026 in Riyadh. For Media Inquiry Email: [email protected] Telephone: +966 559 810 777
- AI Integration Reshapes the 5G Chipset Landscape as Global AI Spending Surpasses $300 Billion, Unlocking a New Era of Silicon Investment“AI and 5G are converging at the silicon level, creating new demand for faster, smarter and more energy-efficient chip architectures.”
- Global Experts Validate TRACE System at UN Geneva: Petrolíferos Lobo and OZ Studio Cement Position as the Ultimate Energy Gateway to MexicoUN experts validation positions Petrolíferos Lobo and OZ Studio's TRACE platform as a verifiable, data-sovereign standard for compliant cross-border energy trade into Mexico.
- Technology Empowers Elegance: LEPAS Redefines the New Energy Mobility ExperienceCompanies: CheryLEPAS believes technology delivers real value when it brings greater comfort and ease to every journey.
- On the regulation of the services provided by AB "Ignitis gamyba"AB “Ignitis grupė“ (hereinafter – the Group) informs that on 27 August 2026, National Energy Regulatory Council (hereinafter – NERC) passed a resolution (link), extending the regulation of manual frequency restoration reserve (hereinafter – mFRR) services provided by Kruonis PSHP and Kaunas HPP of AB “Ignitis gamyba“ until 31 December 2026.
- TAG Oil Ltd.TAG Oil Provides Financial Results and Operating Updates for First Half 2026TAG Oil Ltd. (TSXV: TAO) (OTCQB: TAOIF) (FSE: T0P) ("TAG Oil" or the "Company") is pleased to report the filing of its financial results for the six-month period ending June 30, 2026. A copy of TAG Oil's financial statements, and management discussion and analysis for the period ending June 30, 2026, are available on SEDAR+ (www.sedarplus.ca) and on the Company's website (http://www.tagoil.com/). On June 30, 2026, the Company had...
- Dune Oil Corp.Dune Oil Announces New Director Management Appointment and AGMDune Oil (CSE: DUNE) (OTCQB: TRLEF) (FSE: Z621) ("Dune" or the "Company") is pleased to advise on the following management and director appointments as well as timing of the annual general meeting.2026 Annual General MeetingThe Company announces that its 2026 Annual General Meeting of Shareholders (the "AGM") will be held on Monday, November 16, 2026. The Company intends to use notice-and-access for the AGM, with the management...
- VVater LLCVVater Expands Global Presence Through New Partnership in Asia-Pacific and the Middle EastAUSTIN, TX, Aug 27, 2026 - VVater, America's Next Water Company and the world's premier innovator in advanced water treatment solutions, today announced an expanded international presence across Asia-Pacific Middle East (APME) as the company continues to scale its innovative water treatment technology globally and support new sectors. Via a new partnership agreement, VVater APME will be established. This newly formed venture will bring VVater's technology to a wide range of markets and strategic customers around the world as water scarcity, water quality, regulatory expectations and long-term water stewardship become increasingly important drivers of operational resilience and economic performance. VVater APME is a partnership formed between VVater and Ecosafe International, a regionally recognised water risk management and water stewardship consultancy, which supports organisations to navigate their water journey through governance, assurance, risk reduction and practical innovation. With an extensive track record supporting organisations including BHP, Rio Tinto, Chevron, Shell, JLL and NEOM, Ecosafe advises governments, mining operators, healthcare and industrial organisations on achieving safer, more sustainable and more resilient water outcomes across APME. VVater APME will operate with dedicated sector exclusivity in Australia, New Zealand, Saudi Arabia, Qatar and the UAE. "What drew us to this partnership is how much overlap there already was," said Kevin Gast, CEO and Chairman of VVater. "Ecosafe has spent years building trust with operators in some of the toughest water environments in the world. Pairing that with our technology means we can move faster into markets that badly need it." "For years we've watched clients wrestle with sourcing credible, provable water treatment technology once a risk assessment tells them what they're up against," said Ryan Milne, Founder of Ecosafe International. "This partnership closes a critical gap for us. We've always helped clients understand and govern water risk. Now we can combine that trusted advisory capability with proven technology solutions that accelerate the transition from water risk to water certainty." VVater APME is designed with a defined path to expand into installation, operations, and eventually in-territory manufacturing, creating long-term capability and supporting regional water security outcomes as the partnership matures. The agreement gives VVater APME access to VVater's full suite of proprietary technology, led by the Farady Reactor, a breakthrough in water treatment. Wherever it's deployed, from remote, self-managed water systems and mine sites to municipal water systems and industrial plants, the Farady Reactor transforms wastewater, sewage and drinking water alike, offering a glimpse of what next-generation water infrastructure can look like. VVater APME is the latest step in the company's international growth, following recognition from TIME, CES and Fast Company, and deployments with partners including Nestle and the City of Bastrop, Texas. The agreement reflects VVater's continued push to bring advanced treatment and reuse technology into markets facing mounting water stress. About VVater VVater is America's Next Water Company, delivering the future of purification through its award-winning Farady Reactor (Time Best Invention Award 2025, CES Best of Innovation 2025, World Future Award 2025. The first company in history to win all 3 in 1 year achieving a Triple Crown), proprietary ALTEP (Advanced Low Tension Electroporation Process), Advanced Dissolved Air Flotation, and Micro & Nano Bubble technologies. Unlike outdated chemical, filtration, and membrane systems, VVater's electric-field breakthroughs eliminate microplastics, microorganisms, and other contaminants with record retention times, without producing toxic byproducts or requiring costly consumables. With over 4.3B gallons treated and validation from global leaders, VVater is scaling into municipal drinking water and wastewater, DPR/IPR, onsite reuse for data centers, commercial buildings, and resorts, residential purification, and consumer health water, delivering a 60% smaller footprint, 40% CapEx savings, 80% OpEx savings, and 40% less energy use. For more information, please visit www.vvater.com. Contact Information VVATER Media Office Global Media Room [email protected] Nicholas Koulermos [email protected] SOURCE: VVater LLC